AIM ImmunoTech Inc. AIM
Set alert
0.16 USD 0.00 +1.80%
As of Nov 3, 11:24 AM ET
0.1607 Day range 0.1641
0.15 52-week range 1.96
- YTD
- -85.13%
- 1 year
- -91.61%
- Open
- 0.1607
- Prev close
- 0.1607
- Mkt cap
- 6.53M
- Vol
- 97.14K
- Avg vol
- 4.62M
- EPS
- -2.98
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.1607
- High
- 0.1641
- Forward P/E
- -0.48
- Beta
- -0.36
- Short ratio
- 1.63
- Inst. own
- 14.07%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.232
- 200-d avg
- 0.338
- 1y target
- 2.75
6M chart
Signals (21)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 15, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 14, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 8, 2026 | 3 weeks ago |
| RSI: Oversold | Sep 28, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 24, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 22, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 11, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 9, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 8, 2026 | 1 month ago |
| MACD: Buy Signal | Jul 16, 2026 | 3 months ago |
| MACD: Sell Signal | Jun 11, 2026 | 4 months ago |
| SMA: Bearish | Jun 9, 2026 | 4 months ago |
| SMA: Bearish | Jun 3, 2026 | 5 months ago |
| SMA: Bullish | Jun 1, 2026 | 5 months ago |
| SMA: Bullish | Jun 1, 2026 | 5 months ago |
| RSI: Overbought | Jun 1, 2026 | 5 months ago |
| MACD: Buy Signal | May 27, 2026 | 5 months ago |
| MACD: Sell Signal | May 20, 2026 | 5 months ago |
| MACD: Buy Signal | May 19, 2026 | 5 months ago |
| MACD: Sell Signal | May 11, 2026 | 5 months ago |
Newest 20 of 21.
Financial health
Altman Z-Score
-51.33 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 2
- P/E 1
- P/B 5
Valuation
P/E -0.1×
FY 2016 5y median -1.9× FY 2025
P/S 20.8×
FY 2016 5y median 274× FY 2025
P/B -0.2×
FY 2016 5y median 1.0× FY 2025
P/FCF -0.2×
FY 2016 5y median -2.4× FY 2025
EV/EBITDA -0.4×
FY 2016 5y median -1.8× FY 2025
EV/Sales 65.8×
FY 2016 5y median 178× FY 2025
FCF Yield -619.7%
FY 2016 5y median -42.4% FY 2025
Profitability
Gross Margin -284.1%
FY 2016 5y median 79.2% FY 2025
Operating Margin -11961.4%
FY 2016 5y median -13954.1% FY 2025
Net Margin -15861.4%
FY 2016 5y median -14168.1% FY 2025
ROE 142.7%
FY 2016 5y median -33.6% FY 2025
ROIC -313.6%
FY 2016 5y median -291.4% FY 2025
ROA -241.4%
FY 2016 5y median -149.4% FY 2025
Growth (YoY)
Revenue -48.2%
FY 2016 FY 2025
Operating Income 46.8%
FY 2016 FY 2025
EPS (diluted) 23.2%
FY 2016 FY 2025
Free Cash Flow 24.0%
FY 2016 FY 2025
Financial Health
Current Ratio 0.5×
FY 2016 5y median 1.7× FY 2025
Quick Ratio 0.5×
FY 2016 5y median 1.7× FY 2025
Debt / Equity -0.5×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA -0.3×
FY 2016 5y median 0.2× FY 2025
Interest Coverage -13.0×
FY 2016 5y median -13.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
